当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Kuan-Hsien Lu, Ting-Chia Chang, Chih-Cheng Lai, Wei-Chih Kan, Chung-Han Ho, Kuan-Hung Lin
Patients with stroke are at increased risk of poor outcomes of COVID-19, yet data on prognostic factors of COVID-19 mortality in this population remained limited. In this multicenter retrospective cohort study, we investigated the clinical characteristics of hospitalized patients with COVID-19 and pre-existing stroke and assessed the risk factors for in-hospital mortality. Patients with COVID-19 and a history of stroke between January 1 and September 30, 2022, were included. Clinical data were extracted from electronic medical records. Univariate
and multivariable logistic regression analyses were conducted to identify the risk factors for in-hospital mortality. This study included 282 patients, comprising 57 (20.2%) who died (nonsurvivors) and 225 (79.8%) survivors. Multivariable analyses indicated that higher in-hospital mortality was associated with advanced age (>80 years; odds ratio [OR]: 3.46; 95% Confidence Interval [CI]: 1.70-7.03), residence in a long-term care facility (OR: 2.60; 95% CI: 1.70-5.70), a higher baseline modified Ranking scale score (OR: 1.53; 95% CI: 1.07-2.19), lymphopenia (OR: 3.12; 95% CI: 1.53-6.35), and elevated serum creatinine (OR: 3.86; 95% CI: 1.80-8.26) in patients with COVID-19 and pre-existing stroke.